Lenze Nicholas R, Kazemi Ruby J, Ikeda Allison K, Vijayakumar Punithavathy, Goldstein Cathy A, Stanley Jeffrey J, Brenner Michael J, Hoff Paul T
Department of Otolaryngology - Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan.
Department of Otolaryngology - Head and Neck Surgery, UC Davis Health, Sacramento, California.
J Clin Sleep Med. 2025 Mar 1;21(3):593-597. doi: 10.5664/jcsm.11504.
Consumer sleep technology (CST) has an emerging role in monitoring sleep, including screening or surveillance of sleep disorders; however, few data are available on CST in patients with obstructive sleep apnea. We analyzed attitudes toward CST and patterns of CST use among individuals with obstructive sleep apnea. Among 251 respondents (mean age 57.5 years; 58.2% female), 66.5% reported CST use, and 92.0% indicated that monitoring obstructive sleep apnea treatment response would be a useful feature of CST. Individuals with a household income < $30,000 (odds ratio 0.26; = .008) or identifying as a minority/other race (odds ratio 0.15; = .021) were less likely to use CST. Older age (beta coefficient 0.05; < .001), Medicare insurance (beta coefficient 1.26; = .006), and positive airway pressure use (beta coefficient 1.79; = .008) were associated with increased nights/wk of CST use. These findings demonstrate a high perceived value of CST for monitoring treatment response among individuals with obstructive sleep apnea but disparate use by sociodemographic and clinical factors.
Lenze NR, Kazemi RJ, Ikeda AK, et al. Consumer sleep technology use in individuals with obstructive sleep apnea: does it have a role in monitoring treatment response? 2025;21(3):593-597.
消费者睡眠技术（CST）在睡眠监测中发挥着越来越重要的作用，包括睡眠障碍的筛查或监测；然而，关于阻塞性睡眠呼吸暂停患者使用CST的数据很少。我们分析了阻塞性睡眠呼吸暂停患者对CST的态度和使用模式。在251名受访者（平均年龄57.5岁；58.2%为女性）中，66.5%报告使用过CST，92.0%表示监测阻塞性睡眠呼吸暂停治疗反应将是CST的一个有用功能。家庭收入低于30000美元的个体（比值比0.26；P = 0.008）或认定为少数族裔/其他种族的个体（比值比0.15；P = 0.021）使用CST的可能性较小。年龄较大（β系数0.05；P < 0.001）、参加医疗保险（β系数1.26；P = 0.006）和使用气道正压通气（β系数1.79；P = 0.008）与每周使用CST的天数增加有关。这些发现表明，CST在监测阻塞性睡眠呼吸暂停患者的治疗反应方面具有很高的感知价值，但社会人口统计学和临床因素导致其使用存在差异。
Lenze NR, Kazemi RJ, Ikeda AK,等。阻塞性睡眠呼吸暂停患者使用消费者睡眠技术：它在监测治疗反应中起作用吗？《睡眠与呼吸》2025；21(3):593 - 597。
